Acne Vulgaris - Epidemiology Forecast to 2026 Market Report; Launched via MarketResearchReports.com

Acne vulgaris (acne) is a chronic inflammatory skin disease that presents as open or closed comedones and inflammatory lesions. Comedones include blackheads and whiteheads, while inflammatory lesions include papules, pustules, or cysts. Acne is a common skin disease that predominantly affects adolescents and young adults, but can also persist into adulthood. Mortality is not associated with acne, although major physical and psychological characteristics may develop, such as acne scarring, poor self-esteem, depression, and anxiety. The distribution of acne in the population is influenced by genetic background and dietary habits.

For age- and sex-specific total prevalent cases, Publisher epidemiologists utilized country-specific data from peer-reviewed journal articles, and for age-and sex-specific diagnosed prevalent cases and diagnosed prevalent cases by severity, Publisher epidemiologists utilized a combination of primary research and data obtained from peer-reviewed journal articles. Publisher epidemiologists forecast that the total prevalent cases of acne vulgaris in the 7MM will decrease by an Annual Growth Rate (AGR) of negative 0.13% per year over the next 10 years, from 157,919,985 cases in 2016 to 155,935,706 cases in 2026. Publisher epidemiologists forecast that the diagnosed prevalent cases of acne vulgaris in the 7MM will decrease by an AGR of negative 0.13% per year over the next 10 years, from 78,960,002 cases in 2016 to 77,967,862 cases in 2026. In the 7MM, the US had the highest number of diagnosed prevalent cases with 32,308,734 in 2016, while Spain had the lowest number of diagnosed prevalent cases with 5,766,457 in 2016.

Scope

• The Acne Vulgaris report provides an overview of the risk factors and global trends for acne vulgaris in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
• It includes a 10-year epidemiological forecast for total and diagnosed prevalent cases of acne vulgaris segmented by sex and age (7-9 years, 10-17 years, and 18-60 years). Diagnosed prevalent cases of acne vulgaris are further segmented by severity (mild, moderate, severe) in both children and adolescents (7-17 years) and adults (18-60 years).
• The acne vulgaris epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
• The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy

The Acne Vulgaris Epidemiology report will allow you to -

• Develop business strategies by understanding the trends shaping and driving the global acne vulgaris market.
• Quantify patient populations in the global acne vulgaris market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for acne vulgaris therapeutics in each of the markets covered.
• Understand magnitude of acne vulgaris population by disease severity.

Spanning over 37 pages “Acne Vulgaris - Epidemiology Forecast to 2026” report covers Acne Vulgaris: Executive Summary, Epidemiology, Appendix.

Please visit this link for more details: http://mrr.cm/U8Q

Find all Pharma and Healthcare Reports at: https://www.marketresearchreports.com/pharma-healthcare

Related Report;

OpportunityAnalyzer: Late - Stage Chronic Kidney Disease - Opportunity Analysis and Forecasts to 2026 - Visit at - http://mrr.cm/U8A

United States External Defibrillators Market Outlook to 2025 - Visit at - http://mrr.cm/U8d